PROCTER & GAMBLE HEALTH | JENBURKT PH. | PROCTER & GAMBLE HEALTH/ JENBURKT PH. |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 34.6 | 13.5 | 256.9% | View Chart |
P/BV | x | 10.6 | 2.7 | 392.3% | View Chart |
Dividend Yield | % | 2.0 | 1.9 | 104.2% |
PROCTER & GAMBLE HEALTH JENBURKT PH. |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
PROCTER & GAMBLE HEALTH Jun-23 |
JENBURKT PH. Mar-23 |
PROCTER & GAMBLE HEALTH/ JENBURKT PH. |
5-Yr Chart Click to enlarge
|
||
High | Rs | 5,366 | 760 | 706.0% | |
Low | Rs | 3,883 | 452 | 858.9% | |
Sales per share (Unadj.) | Rs | 740.7 | 310.1 | 238.9% | |
Earnings per share (Unadj.) | Rs | 138.2 | 55.8 | 247.7% | |
Cash flow per share (Unadj.) | Rs | 155.2 | 60.9 | 254.7% | |
Dividends per share (Unadj.) | Rs | 95.00 | 14.40 | 659.7% | |
Avg Dividend yield | % | 2.1 | 2.4 | 86.5% | |
Book value per share (Unadj.) | Rs | 447.6 | 277.5 | 161.3% | |
Shares outstanding (eoy) | m | 16.60 | 4.41 | 376.4% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 6.2 | 2.0 | 319.2% | |
Avg P/E ratio | x | 33.5 | 10.9 | 307.8% | |
P/CF ratio (eoy) | x | 29.8 | 10.0 | 299.3% | |
Price / Book Value ratio | x | 10.3 | 2.2 | 472.7% | |
Dividend payout | % | 68.7 | 25.8 | 266.1% | |
Avg Mkt Cap | Rs m | 76,761 | 2,675 | 2,869.9% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 2,062 | 388 | 531.3% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 12,296 | 1,367 | 899.2% | |
Other income | Rs m | 184 | 51 | 359.0% | |
Total revenues | Rs m | 12,480 | 1,419 | 879.7% | |
Gross profit | Rs m | 3,247 | 304 | 1,069.2% | |
Depreciation | Rs m | 281 | 23 | 1,243.9% | |
Interest | Rs m | 8 | 4 | 209.8% | |
Profit before tax | Rs m | 3,142 | 329 | 956.0% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 847 | 83 | 1,026.0% | |
Profit after tax | Rs m | 2,295 | 246 | 932.5% | |
Gross profit margin | % | 26.4 | 22.2 | 118.9% | |
Effective tax rate | % | 27.0 | 25.1 | 107.3% | |
Net profit margin | % | 18.7 | 18.0 | 103.7% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 11,713 | 811 | 1,444.4% | |
Current liabilities | Rs m | 6,791 | 158 | 4,308.3% | |
Net working cap to sales | % | 40.0 | 47.8 | 83.8% | |
Current ratio | x | 1.7 | 5.1 | 33.5% | |
Inventory Days | Days | 263 | 130 | 201.4% | |
Debtors Days | Days | 343 | 453 | 75.9% | |
Net fixed assets | Rs m | 10,617 | 603 | 1,760.8% | |
Share capital | Rs m | 166 | 44 | 376.2% | |
"Free" reserves | Rs m | 7,265 | 1,180 | 615.8% | |
Net worth | Rs m | 7,431 | 1,224 | 607.1% | |
Long term debt | Rs m | 0 | 0 | - | |
Total assets | Rs m | 22,330 | 1,414 | 1,579.3% | |
Interest coverage | x | 409.1 | 90.6 | 451.7% | |
Debt to equity ratio | x | 0 | 0 | - | |
Sales to assets ratio | x | 0.6 | 1.0 | 56.9% | |
Return on assets | % | 10.3 | 17.7 | 58.4% | |
Return on equity | % | 30.9 | 20.1 | 153.6% | |
Return on capital | % | 42.4 | 27.2 | 156.1% | |
Exports to sales | % | 0 | 18.5 | 0.0% | |
Imports to sales | % | 13.1 | 0 | - | |
Exports (fob) | Rs m | NA | 253 | 0.0% | |
Imports (cif) | Rs m | 1,605 | NA | - | |
Fx inflow | Rs m | 1,465 | 253 | 580.1% | |
Fx outflow | Rs m | 1,605 | 22 | 7,297.3% | |
Net fx | Rs m | -140 | 231 | -60.8% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 2,360 | 171 | 1,384.0% | |
From Investments | Rs m | -215 | 26 | -821.2% | |
From Financial Activity | Rs m | -985 | -210 | 468.0% | |
Net Cashflow | Rs m | 1,160 | -14 | -8,463.2% |
Indian Promoters | % | 0.0 | 33.3 | - | |
Foreign collaborators | % | 51.8 | 14.0 | 371.2% | |
Indian inst/Mut Fund | % | 20.0 | 0.0 | - | |
FIIs | % | 6.2 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 48.2 | 52.8 | 91.3% | |
Shareholders | 56,778 | 6,316 | 899.0% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare PROCTER & GAMBLE HEALTH With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | Procter & Gamble Health | JENBURKT PH. | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -0.43% | 0.83% | 0.45% |
1-Month | -1.15% | 4.71% | 2.55% |
1-Year | 0.73% | 8.55% | 56.14% |
3-Year CAGR | -8.76% | 18.37% | 15.22% |
5-Year CAGR | 4.97% | 8.69% | 19.63% |
* Compound Annual Growth Rate
Here are more details on the Procter & Gamble Health share price and the JENBURKT PH. share price.
Moving on to shareholding structures...
The promoters of Procter & Gamble Health hold a 51.8% stake in the company. In case of JENBURKT PH. the stake stands at 47.2%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Procter & Gamble Health and the shareholding pattern of JENBURKT PH..
Finally, a word on dividends...
In the most recent financial year, Procter & Gamble Health paid a dividend of Rs 95.0 per share. This amounted to a Dividend Payout ratio of 68.7%.
JENBURKT PH. paid Rs 14.4, and its dividend payout ratio stood at 25.8%.
You may visit here to review the dividend history of Procter & Gamble Health, and the dividend history of JENBURKT PH..
For a sector overview, read our pharmaceuticals sector report.
After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.